Press Releases

 
Press Releases
Date Title and Summary View
Sep 9, 2008 CAMBRIDGE, Mass., September 9, 2008 – Zafgen Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics today announced that Thomas Hughes, Ph.D., has been named the company’s first chief executive officer. Dr. Hughes was formerly vice president and global head, cardiovascular and...
Oct 16, 2008 CAMBRIDGE, Mass., October 16, 2008 – Zafgen Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics today announced that Thomas Hughes, Ph.D. will present at the 2008 Boston Biotech R&D Conference, at 8:20 a.m. (EST) on October 22, 2008 at Harvard Medical School. This conference will...
Jan 29, 2009 Harlow, UK and Cambridge, MA, January 29, 2009 – Argenta Discovery Ltd., the contract research and Respiratory R & D company, and Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that they have entered into a major drug discovery collaboration. Under ...
Mar 25, 2009 Cambridge, MA, March 25, 2009 – Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Dr. Thomas Hughes, Ph.D., president and chief executive officer, will present a company overview at several upcoming conferences. ...
Apr 27, 2009 CAMBRIDGE, Mass., April 27, 2009 – Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Thomas Hughes, Ph.D., president and chief executive officer and Maria Rupnick, M.D., Zafgen co-founder, cardiologist at Brigham and Women’s Hospital and instruct...
May 5, 2009 Cambridge, MA, May 5, 2009 – Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced the appointment of Matthias Jaffe to chief financial officer and vice president of business development. Mr. Jaffe brings to Zafgen extensive finance, acquisition and business d...
May 14, 2009 CAMBRIDGE, Mass., May 14, 2009 – Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Thomas Hughes, Ph.D., president and chief executive officer has been selected to participate on a panel at the BIO 2009 International Convention on Tuesday, May 19, 2009...
Jun 8, 2009 CAMBRIDGE, MA, June 8, 2009 – Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Randy J. Seeley, Ph.D., professor of psychiatry and associate director for the Metabolic Disease Institute at the University of Cincinnati College of Medicine, and a member...
Jun 9, 2009 New Orleans, LA (June 9, 2009) – The American Diabetes Association, the nation’s leading voluntary health organization in the fight against diabetes, announced today that several leading researchers, clinicians, and educators in the diabetes field were presented with awards at the organization’s 69th Scientific Sessions, which ...
Jun 17, 2009 CAMBRIDGE, MA, June 17, 2009 – Zafgen, Inc., a private venture-backed biopharmaceutical company focused on developing novel obesity therapeutics, today announced that Thomas Hughes, Ph.D., president and chief executive officer and Maria Rupnick, M.D., Zafgen cofounder, cardiologist at Brigham and Women’s Hospital and instructor of...
Page:
1
... NextLast
= add release to Briefcase